Venker Eric, President and Immunovant CEO, sold Roivant Sciences Ltd. ($ROIV) shares on the open market 27 times over the past year, totaling $101.8 million. His most recent sale occurred on February 13, 2026. These sales rank 160th among 11,678 insiders in our database, surpassing the average of $8.6 million per seller and 6.4 transactions. Venker Eric made no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 1, 2026 | Immunovant, Inc. | $IMVT | Venker Eric | Chief Executive Officer | M | Capped Value Appreciation Rights | 368750 | $0.00 | 1,106,250.0000 | 203,532,180 | 25.00% | 0.18% |
| April 2, 2026 | Immunovant, Inc. | $IMVT | Venker Eric | Chief Executive Officer | S | Common Stock | 12820 | $24.04 | 20,970.0000 | 203,532,180 | 37.94% | 0.01% |
| April 1, 2026 | Immunovant, Inc. | $IMVT | Venker Eric | Chief Executive Officer | D | Common Stock | 334960 | $25.10 | 33,790.0000 | 203,532,180 | 90.84% | 0.16% |
| April 1, 2026 | Immunovant, Inc. | $IMVT | Venker Eric | Chief Executive Officer | M | Common Stock | 368750 | $14.46 | 368,750.0000 | 203,532,180 | 9999.99% | 0.18% |
| April 2, 2026 | Immunovant, Inc. | $IMVT | Venker Eric | Chief Executive Officer | S | Common Stock | 1409 | $24.60 | 19,561.0000 | 203,532,180 | 6.72% | 0.00% |
| March 17, 2026 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Stock Option (Right to Buy) | 200000 | $0.00 | 4,844,834.0000 | 696,859,682 | 3.96% | 0.03% |
| March 17, 2026 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Common Shares | 200000 | $3.85 | 1,847,546.0000 | 696,859,682 | 12.14% | 0.03% |
| March 17, 2026 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | S | Common Shares | 200000 | $28.24 | 1,647,546.0000 | 696,859,682 | 10.83% | 0.03% |
| Feb. 20, 2026 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | F | Common Shares | 7051 | $27.15 | 1,647,546.0000 | 696,859,682 | 0.43% | 0.00% |
| Feb. 13, 2026 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Common Shares | 200000 | $3.85 | 1,854,597.0000 | 696,859,682 | 12.09% | 0.03% |
| Feb. 13, 2026 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | S | Common Shares | 200000 | $26.49 | 1,654,597.0000 | 696,859,682 | 10.78% | 0.03% |
| Feb. 13, 2026 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Stock Option (Right to Buy) | 200000 | $0.00 | 5,044,834.0000 | 696,859,682 | 3.81% | 0.03% |
| Jan. 12, 2026 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Common Shares | 200000 | $3.85 | 1,854,597.0000 | 696,859,682 | 12.09% | 0.03% |
| Jan. 12, 2026 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Stock Option (Right to Buy) | 200000 | $0.00 | 5,244,834.0000 | 696,859,682 | 3.67% | 0.03% |
| Jan. 12, 2026 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | S | Common Shares | 200000 | $21.92 | 1,654,597.0000 | 696,859,682 | 10.78% | 0.03% |
| Dec. 24, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | S | Common Shares | 75000 | $22.53 | 1,654,597.0000 | 680,947,866 | 4.34% | 0.01% |
| Dec. 24, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Common Shares | 117848 | $3.85 | 1,729,597.0000 | 680,947,866 | 7.31% | 0.02% |
| Dec. 23, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | S | Common Shares | 200000 | $22.45 | 1,611,749.0000 | 680,947,866 | 11.04% | 0.03% |
| Dec. 23, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Common Shares | 313841 | $3.85 | 1,811,749.0000 | 680,947,866 | 20.95% | 0.05% |
| Dec. 24, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Stock Option (Right to Buy) | 117848 | $0.00 | 5,444,834.0000 | 680,947,866 | 2.12% | 0.02% |
| Dec. 23, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Stock Option (Right to Buy) | 313841 | $0.00 | 5,562,682.0000 | 680,947,866 | 5.34% | 0.05% |
| Dec. 9, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Common Shares | 200000 | $3.85 | 1,697,908.0000 | 680,947,866 | 13.35% | 0.03% |
| Dec. 9, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Stock Option (Right to Buy) | 200000 | $0.00 | 5,876,523.0000 | 680,947,866 | 3.29% | 0.03% |
| Dec. 9, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | S | Common Shares | 200000 | $20.85 | 1,497,908.0000 | 680,947,866 | 11.78% | 0.03% |
| Nov. 20, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | F | Common Shares | 7051 | $20.27 | 1,497,908.0000 | 680,947,866 | 0.47% | 0.00% |
| Nov. 7, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Common Shares | 200000 | $3.85 | 1,704,959.0000 | 680,947,866 | 13.29% | 0.03% |
| Nov. 7, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | S | Common Shares | 200000 | $20.22 | 1,504,959.0000 | 680,947,866 | 11.73% | 0.03% |
| Nov. 7, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Stock Option (Right to Buy) | 200000 | $20.22 | 6,076,523.0000 | 680,947,866 | 3.19% | 0.03% |
| Oct. 15, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Stock Option (Right to Buy) | 414683 | $0.00 | 436,700.0000 | 680,947,866 | 48.71% | 0.06% |
| Oct. 17, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | S | Common Shares | 118418 | $17.06 | 1,504,959.0000 | 680,947,866 | 7.29% | 0.02% |
| Oct. 17, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Common Shares | 118418 | $15.85 | 1,623,377.0000 | 680,947,866 | 7.87% | 0.02% |
| Oct. 16, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | S | Common Shares | 318282 | $17.05 | 1,504,959.0000 | 680,947,866 | 17.46% | 0.05% |
| Oct. 16, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Common Shares | 318282 | $15.85 | 1,823,241.0000 | 680,947,866 | 21.15% | 0.05% |
| Oct. 15, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | S | Common Shares | 414683 | $16.93 | 1,504,959.0000 | 680,947,866 | 21.60% | 0.06% |
| Oct. 15, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Common Shares | 414683 | $15.85 | 1,919,642.0000 | 680,947,866 | 27.55% | 0.06% |
| Oct. 17, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Stock Option (Right to Buy) | 118418 | $0.00 | 0.0000 | 680,947,866 | 100.00% | 0.02% |
| Oct. 16, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Stock Option (Right to Buy) | 318282 | $0.00 | 118,418.0000 | 680,947,866 | 72.88% | 0.05% |
| Oct. 13, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Common Shares | 20727 | $15.85 | 1,525,686.0000 | 680,947,866 | 1.38% | 0.00% |
| Oct. 13, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Stock Option (Right to Buy) | 20727 | $0.00 | 851,383.0000 | 680,947,866 | 2.38% | 0.00% |
| Oct. 9, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Stock Option (Right to Buy) | 104940 | $0.00 | 872,110.0000 | 680,947,866 | 10.74% | 0.02% |
| Oct. 13, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | S | Common Shares | 20727 | $16.25 | 1,504,959.0000 | 680,947,866 | 1.36% | 0.00% |
| Oct. 9, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | S | Common Shares | 104940 | $16.30 | 1,504,959.0000 | 680,947,866 | 6.52% | 0.02% |
| Oct. 9, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Common Shares | 104940 | $15.85 | 1,609,899.0000 | 680,947,866 | 6.97% | 0.02% |
| Oct. 7, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Stock Option (Right to Buy) | 67171 | $0.00 | 987,357.0000 | 680,947,866 | 6.37% | 0.01% |
| Oct. 6, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Stock Option (Right to Buy) | 19141 | $0.00 | 6,457,382.0000 | 680,947,866 | 0.30% | 0.00% |
| Oct. 6, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Stock Option (Right to Buy) | 24900 | $0.00 | 235,426.0000 | 680,947,866 | 9.56% | 0.00% |
| Oct. 6, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Stock Option (Right to Buy) | 127355 | $0.00 | 1,054,528.0000 | 680,947,866 | 10.78% | 0.02% |
| Oct. 8, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | S | Common Shares | 138602 | $16.20 | 1,504,959.0000 | 680,947,866 | 8.43% | 0.02% |
| Oct. 8, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Common Shares | 128295 | $7.45 | 1,643,561.0000 | 680,947,866 | 8.47% | 0.02% |
| Oct. 8, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Common Shares | 10307 | $15.85 | 1,515,266.0000 | 680,947,866 | 0.68% | 0.00% |
| Oct. 7, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | S | Common Shares | 355161 | $16.15 | 1,504,959.0000 | 680,947,866 | 19.09% | 0.05% |
| Oct. 8, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Stock Option (Right to Buy) | 128295 | $0.00 | 0.0000 | 680,947,866 | 100.00% | 0.02% |
| Oct. 8, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Stock Option (Right to Buy) | 10307 | $0.00 | 977,050.0000 | 680,947,866 | 1.04% | 0.00% |
| Oct. 7, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Common Shares | 180859 | $3.85 | 1,860,120.0000 | 680,947,866 | 10.77% | 0.03% |
| Oct. 7, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Common Shares | 107131 | $7.45 | 1,679,261.0000 | 680,947,866 | 6.81% | 0.02% |
| Oct. 7, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Common Shares | 67171 | $15.85 | 1,572,130.0000 | 680,947,866 | 4.46% | 0.01% |
| Oct. 6, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | S | Common Shares | 171396 | $16.34 | 1,504,959.0000 | 680,947,866 | 10.22% | 0.03% |
| Oct. 6, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Common Shares | 19141 | $3.85 | 1,676,355.0000 | 680,947,866 | 1.16% | 0.00% |
| Oct. 6, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Common Shares | 24900 | $7.45 | 1,657,214.0000 | 680,947,866 | 1.53% | 0.00% |
| Oct. 6, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Common Shares | 127355 | $15.85 | 1,632,314.0000 | 680,947,866 | 8.46% | 0.02% |
| Oct. 7, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Stock Option (Right to Buy) | 180859 | $0.00 | 6,276,523.0000 | 680,947,866 | 2.80% | 0.03% |
| Oct. 7, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Stock Option (Right to Buy) | 107131 | $0.00 | 128,295.0000 | 680,947,866 | 45.51% | 0.02% |
| Sept. 22, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Stock Option (Right to Buy) | 100000 | $0.00 | 6,476,523.0000 | 725,395,624 | 1.52% | 0.01% |
| Sept. 22, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Stock Option (Right to Buy) | 462374 | $0.00 | 6,576,523.0000 | 725,395,624 | 6.57% | 0.06% |
| Sept. 19, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Stock Option (Right to Buy) | 1000000 | $0.00 | 7,038,897.0000 | 725,395,624 | 12.44% | 0.14% |
| Sept. 23, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | S | Common Shares | 611000 | $14.83 | 1,504,959.0000 | 725,395,624 | 28.88% | 0.08% |
| Sept. 22, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | S | Common Shares | 100000 | $15.01 | 2,115,959.0000 | 725,395,624 | 4.51% | 0.01% |
| Sept. 22, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | S | Common Shares | 316182 | $14.99 | 2,215,959.0000 | 725,395,624 | 12.49% | 0.04% |
| Sept. 22, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Common Shares | 100000 | $3.85 | 2,532,141.0000 | 725,395,624 | 4.11% | 0.01% |
| Sept. 22, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Common Shares | 462374 | $3.85 | 2,432,141.0000 | 725,395,624 | 23.47% | 0.06% |
| Sept. 19, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | S | Common Shares | 683818 | $14.95 | 1,969,767.0000 | 725,395,624 | 25.77% | 0.09% |
| Sept. 19, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Common Shares | 1000000 | $3.85 | 2,653,585.0000 | 725,395,624 | 60.47% | 0.14% |
| Aug. 20, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Common Shares | 100000 | $3.85 | 1,753,585.0000 | 725,395,624 | 6.05% | 0.01% |
| Aug. 20, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | F | Common Shares | 7051 | $11.72 | 1,653,585.0000 | 725,395,624 | 0.42% | 0.00% |
| Aug. 20, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | S | Common Shares | 100000 | $11.72 | 1,653,585.0000 | 725,395,624 | 5.70% | 0.01% |
| Aug. 20, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Stock Option (Right to Buy) | 100000 | $0.00 | 8,038,897.0000 | 725,395,624 | 1.23% | 0.01% |
| July 30, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | A | Common Shares | 198413 | $0.00 | 1,660,636.0000 | 725,395,624 | 13.57% | 0.03% |
| July 28, 2025 | Immunovant, Inc. | $IMVT | Venker Eric | Chief Executive Officer | A | Capped Value Appreciation Rights | 1475000 | $0.00 | 1,475,000.0000 | 170,923,191 | 9999.99% | 0.86% |
| July 28, 2025 | Immunovant, Inc. | $IMVT | Venker Eric | Chief Executive Officer | A | Stock Option (right to buy) | 1300000 | $0.00 | 1,300,000.0000 | 170,923,191 | 9999.99% | 0.76% |
| July 28, 2025 | Immunovant, Inc. | $IMVT | Venker Eric | Chief Executive Officer | A | Stock Option (right to buy) | 189900 | $0.00 | 189,900.0000 | 170,923,191 | 9999.99% | 0.11% |
| July 21, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Common Shares | 100000 | $3.85 | 1,562,223.0000 | 725,395,624 | 6.84% | 0.01% |
| July 21, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | S | Common Shares | 100000 | $11.52 | 1,462,223.0000 | 725,395,624 | 6.40% | 0.01% |
| July 21, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & Immunovant CEO | M | Stock Option (Right to Buy) | 100000 | $0.00 | 8,138,897.0000 | 725,395,624 | 1.21% | 0.01% |
| June 20, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Stock Option (Right to Buy) | 100000 | $0.00 | 8,238,897.0000 | 725,395,624 | 1.20% | 0.01% |
| June 20, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Common Shares | 100000 | $3.85 | 1,562,223.0000 | 725,395,624 | 6.84% | 0.01% |
| June 20, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | S | Common Shares | 100000 | $11.45 | 1,462,223.0000 | 725,395,624 | 6.40% | 0.01% |
| June 2, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Stock Option (Right to Buy) | 600000 | $0.00 | 9,123,923.0000 | 725,395,624 | 6.17% | 0.08% |
| June 2, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Common Shares | 600000 | $3.85 | 1,677,197.0000 | 725,395,624 | 55.70% | 0.08% |
| June 2, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | S | Common Shares | 433722 | $11.07 | 1,243,475.0000 | 725,395,624 | 25.86% | 0.06% |
| June 3, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Common Shares | 785026 | $3.85 | 2,028,501.0000 | 725,395,624 | 63.13% | 0.11% |
| June 3, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | S | Common Shares | 566278 | $11.22 | 1,462,223.0000 | 725,395,624 | 27.92% | 0.08% |
| June 3, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Stock Option (Right to Buy) | 785026 | $0.00 | 8,338,897.0000 | 725,395,624 | 8.60% | 0.11% |
| May 20, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | S | Common Shares | 100000 | $10.95 | 1,077,197.0000 | 725,395,624 | 8.49% | 0.01% |
| May 20, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | F | Common Shares | 39148 | $11.04 | 1,077,197.0000 | 725,395,624 | 3.51% | 0.01% |
| May 20, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Common Shares | 100000 | $3.85 | 1,177,197.0000 | 725,395,624 | 9.28% | 0.01% |
| May 20, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Stock Option (Right to Buy) | 100000 | $0.00 | 9,723,923.0000 | 725,395,624 | 1.02% | 0.01% |
| April 21, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | S | Common Shares | 100000 | $10.22 | 1,116,345.0000 | 725,395,624 | 8.22% | 0.01% |
| April 20, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | F | Common Shares | 10945 | $10.15 | 1,116,345.0000 | 725,395,624 | 0.97% | 0.00% |
| April 21, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Common Shares | 100000 | $3.85 | 1,216,345.0000 | 725,395,624 | 8.96% | 0.01% |
| April 21, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Stock Option (Right to Buy) | 100000 | $0.00 | 9,823,923.0000 | 725,395,624 | 1.01% | 0.01% |
| March 20, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Stock Option (Right to Buy) | 400000 | $0.00 | 10,526,234.0000 | 731,318,202 | 3.66% | 0.05% |
| March 20, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | F | Common Shares | 10945 | $10.97 | 874,979.0000 | 731,318,202 | 1.24% | 0.00% |
| March 20, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Common Shares | 400000 | $3.85 | 1,274,979.0000 | 731,318,202 | 45.72% | 0.05% |
| March 20, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | S | Common Shares | 315522 | $11.06 | 959,457.0000 | 731,318,202 | 24.75% | 0.04% |
| March 24, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Common Shares | 602311 | $3.85 | 1,561,768.0000 | 731,318,202 | 62.78% | 0.08% |
| March 24, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | S | Common Shares | 434478 | $10.82 | 1,127,290.0000 | 731,318,202 | 27.82% | 0.06% |
| March 24, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Stock Option (Right to Buy) | 602311 | $0.00 | 9,923,923.0000 | 731,318,202 | 5.72% | 0.08% |
| Feb. 20, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | F | Common Shares | 10945 | $10.72 | 885,924.0000 | 731,318,202 | 1.22% | 0.00% |
| Feb. 20, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Common Shares | 100000 | $3.85 | 996,869.0000 | 731,318,202 | 11.15% | 0.01% |
| Feb. 20, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | S | Common Shares | 100000 | $10.65 | 896,869.0000 | 731,318,202 | 10.03% | 0.01% |
| Feb. 20, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Stock Option (Right to Buy) | 100000 | $0.00 | 10,926,234.0000 | 731,318,202 | 0.91% | 0.01% |
| Feb. 13, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Stock Option (Right to Buy) | 300000 | $0.00 | 11,026,234.0000 | 731,318,202 | 2.65% | 0.04% |
| Feb. 12, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Stock Option (Right to Buy) | 300000 | $0.00 | 11,326,234.0000 | 731,318,202 | 2.58% | 0.04% |
| Feb. 13, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | S | Common Shares | 218041 | $10.42 | 896,869.0000 | 731,318,202 | 19.56% | 0.03% |
| Feb. 13, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Common Shares | 300000 | $3.85 | 1,114,910.0000 | 731,318,202 | 36.81% | 0.04% |
| Feb. 12, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | S | Common Shares | 217384 | $10.53 | 732,294.0000 | 731,318,202 | 22.89% | 0.03% |
| Feb. 12, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Common Shares | 300000 | $3.85 | 1,032,294.0000 | 731,318,202 | 40.97% | 0.04% |
| Jan. 21, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Common Shares | 100000 | $3.85 | 832,294.0000 | 731,318,202 | 13.66% | 0.01% |
| Jan. 21, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | S | Common Shares | 100000 | $11.28 | 732,294.0000 | 731,318,202 | 12.01% | 0.01% |
| Jan. 21, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Stock Option (Right to Buy) | 100000 | $0.00 | 11,626,234.0000 | 731,318,202 | 0.85% | 0.01% |
| Jan. 20, 2025 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | F | Common Shares | 8682 | $11.15 | 732,294.0000 | 731,318,202 | 1.17% | 0.00% |
| Dec. 30, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | S | Common Shares | 177704 | $11.54 | 740,976.0000 | 735,642,721 | 19.34% | 0.02% |
| Dec. 30, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Stock Option (Right to Buy) | 250000 | $0.00 | 11,726,234.0000 | 735,642,721 | 2.09% | 0.03% |
| Dec. 27, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Stock Option (Right to Buy) | 250000 | $0.00 | 11,976,234.0000 | 735,642,721 | 2.04% | 0.03% |
| Dec. 27, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Common Shares | 250000 | $3.85 | 845,580.0000 | 735,642,721 | 41.98% | 0.03% |
| Dec. 27, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | S | Common Shares | 176900 | $11.82 | 668,680.0000 | 735,642,721 | 20.92% | 0.02% |
| Dec. 30, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Common Shares | 250000 | $3.85 | 918,680.0000 | 735,642,721 | 37.39% | 0.03% |
| Dec. 20, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | S | Common Shares | 100000 | $11.49 | 595,580.0000 | 735,642,721 | 14.38% | 0.01% |
| Dec. 20, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | F | Common Shares | 10945 | $11.57 | 595,580.0000 | 735,642,721 | 1.80% | 0.00% |
| Dec. 20, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Common Shares | 100000 | $3.85 | 695,580.0000 | 735,642,721 | 16.79% | 0.01% |
| Dec. 20, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Stock Option (Right to Buy) | 100000 | $0.00 | 12,226,234.0000 | 735,642,721 | 0.81% | 0.01% |
| Nov. 20, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | S | Common Shares | 100000 | $11.32 | 606,525.0000 | 735,642,721 | 14.15% | 0.01% |
| Nov. 20, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | F | Common Shares | 10945 | $11.49 | 606,525.0000 | 735,642,721 | 1.77% | 0.00% |
| Nov. 20, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Common Shares | 100000 | $3.85 | 706,525.0000 | 735,642,721 | 16.49% | 0.01% |
| Nov. 20, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Stock Option (Right to Buy) | 100000 | $0.00 | 12,326,234.0000 | 735,642,721 | 0.80% | 0.01% |
| Oct. 21, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | S | Common Shares | 100000 | $11.65 | 617,470.0000 | 735,642,721 | 13.94% | 0.01% |
| Oct. 20, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | F | Common Shares | 10945 | $11.92 | 617,470.0000 | 735,642,721 | 1.74% | 0.00% |
| Oct. 21, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Common Shares | 100000 | $3.85 | 717,470.0000 | 735,642,721 | 16.20% | 0.01% |
| Oct. 21, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Stock Option (Right to Buy) | 100000 | $0.00 | 12,426,234.0000 | 735,642,721 | 0.80% | 0.01% |
| Sept. 20, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | F | Common Shares | 10945 | $11.97 | 628,415.0000 | 831,049,444 | 1.71% | 0.00% |
| Aug. 20, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | F | Common Shares | 10947 | $11.48 | 639,360.0000 | 831,049,444 | 1.68% | 0.00% |
| July 26, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | A | Common Shares | 204000 | $0.00 | 650,307.0000 | 831,049,444 | 45.71% | 0.02% |
| July 26, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | A | Stock Option (Right to Buy) | 409000 | $0.00 | 409,000.0000 | 831,049,444 | 9999.99% | 0.05% |
| July 20, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | F | Common Shares | 10945 | $11.00 | 446,307.0000 | 831,049,444 | 2.39% | 0.00% |
| June 20, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | F | Common Shares | 10945 | $10.80 | 457,252.0000 | 831,049,444 | 2.34% | 0.00% |
| May 20, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | F | Common Shares | 16003 | $11.37 | 468,197.0000 | 831,049,444 | 3.31% | 0.00% |
| April 20, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | F | Common Shares | 16002 | $10.46 | 484,200.0000 | 831,049,444 | 3.20% | 0.00% |
| March 20, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | F | Common Shares | 16003 | $10.01 | 500,202.0000 | 712,791,115 | 3.10% | 0.00% |
| Feb. 20, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | F | Common Shares | 16002 | $11.54 | 516,205.0000 | 712,791,115 | 3.01% | 0.00% |
| Feb. 9, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Stock Option (Right to Buy) | 96950 | $0.00 | 12,526,234.0000 | 712,791,115 | 0.77% | 0.01% |
| Feb. 9, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | S | Common Shares | 96950 | $10.92 | 532,207.0000 | 712,791,115 | 15.41% | 0.01% |
| Feb. 9, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | M | Common Shares | 96950 | $3.85 | 629,157.0000 | 712,791,115 | 18.22% | 0.01% |
| Jan. 20, 2024 | Roivant Sciences Ltd. | $ROIV | Venker Eric | President & COO | F | Common Shares | 12377 | $10.35 | 532,207.0000 | 712,791,115 | 2.27% | 0.00% |